title: The utility of amnioinfusion in the prophylaxis of meconium-stained amniotic fluid infectious morbidity.
abstract: OBJECTIVE
  To evaluate the utility of intrapartum amnioinfusion (AI) in reducing the infectious morbidity of patients with meconium-stained fluid (MSF). Previous studies have shown increased intraamniotic infection (IAI) and postpartum endometritis (PPE) rates in patients with MSF. Intraamniotic infection has been reduced with the prophylactic administration of ampicillin-sulbactam in MSF. Intraamniotic infection and PPE have been reduced with the use of AI in patients with clear fluid. No investigators have specifically examined the efficacy of AI in reducing meconium-stained, amniotic-fluid-associated infectious morbidity.
  
  
  METHODS
  A retrospective cohort study of all cases of MSF was conducted and included patients who delivered at Louisiana State University Medical Center-Shreveport during the one-year period from January to December 1996. Patients were identified from the perinatal database by the diagnosis code of MSF. The medical records were reviewed to determine the consistency of MSF and the presence or absence of infectious morbidity. Patient demographics, labor characteristics, and various risk factors for infection were sought. The main outcome measures were the occurrence of clinical IAI or PPE. Statistical analysis included two-tailed unpaired t-test, X(2), ANOVA, and Fisher exact test when appropriate.
  
  
  RESULTS
  Two hundred seventy-three medical records of patients with MSF were studied. One hundred twenty nine patients received AI, and 144 did not receive AI. No significant differences in demographics, labor characteristics, or outcome variables were noted between the two groups. The incidences of IAI were 18.6% and 24.3%, P = 0.13, in the AI and non-AI groups, respectively. Postpartum endometritis occurred in 22.5% of AI patients and 21.5% of non-AI patients, P = 0.97.
  
  
  CONCLUSIONS
  The use of AI confers no benefit for the reduction of infectious morbidity in patients with MSF.
authors.affiliation: Department of Obstetrics and Gynecology Louisiana State University Medical Center P.O. Box 33932 1501 Kings Highway Shreveport LA USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Adair
authors.forename: J W
authors.initials: JW
authors.lastname: Weeks
authors.forename: G
authors.initials: G
authors.lastname: Johnson
authors.forename: S
authors.initials: S
authors.lastname: Burlison
authors.forename: S
authors.initials: S
authors.lastname: London
authors.forename: D F
authors.initials: DF
authors.lastname: Lewis